Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureJon S. Odorico, Antonio Citro, Thomas H. Kay, Esther Latres, Jeffrey R. Millman, Maria Cristina Nostro, Lorenzo Piemonti, Michael R. Rickels, Holger A. Russ, Kevin Alessandri, Joana Almaça, Juan R. Alvarez-Dominguez, Diego Balboa, Jessie M. Barra, Thomas Bollenbach, Michael Brehm, Remi J. Creusot, Jacques Galipeau, Nathaniel Hogrebe, Christian Honore, Danwei Huangfu, Eddie A. James, Norma S. Kenyon, Minglin Ma, Marjana Marinac, Maki Nakayama, Audrey V. Parent, Edward A. Phelps, Alvin C. Powers, Trevor Reichman, Bart O. Roep, Sonja Schrepfer, Peter Stock, Piotr Witkowski, James F. Markmann
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Embryonic stem cell lines derived from human blastocysts.
10.1126/science.282.5391.1145 · 1998
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
10.1016/j.cell.2007.11.019 · 2007
Induced pluripotent stem cell lines derived from human somatic cells.
10.1126/science.1151526 · 2007
Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes.
10.1016/j.stem.2021.10.003 · 2021
Stem cell-derived, fully differentiated islets for type 1 diabetes.
10.1056/nejmoa2506549 · 2025
Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient.
10.1016/j.cell.2024.09.004 · 2024
Treating a type 2 diabetic patient with impaired pancreatic islet function by personalized endoderm stem cell-derived islet tissue.
10.1038/s41421-024-00662-3 · 2024
Autologous induced stem-cell-derived retinal cells for macular degeneration.
10.1056/nejmoa1608368 · 2017
Personalized iPSC-derived dopamine progenitor cells for parkinson’s disease.
10.1056/nejmoa1915872 · 2020
iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study.
10.1182/blood.2022017296 · 2022
Human pluripotent stem cell-based cardiac repair: lessons learned and challenges ahead.
10.1016/j.addr.2025.115594 · 2025
Improvement in glycaemic control and elimination of exogenous insulin use in patients with type 1 diabetes infused with fully differentiated islet cells (VX-880).
2024
Mapping histological and functional maturation of human endocrine pancreas across early postnatal periods.
2024
Understanding islet dysfunction in type 2 diabetes through multidimensional pancreatic phenotyping: the human pancreas analysis program.
10.1016/j.cmet.2022.09.013 · 2022
Alpha cell dysfunction in islets from nondiabetic, glutamic acid decarboxylase autoantibody-positive individuals.
10.1172/jci156243 · 2022
Diabetes as a pancreatic microvascular disease-A pericytic perspective.
10.1369/00221554241236535 · 2024
The pericyte of the pancreatic islet regulates capillary diameter and local blood flow.
10.1016/j.cmet.2018.02.016 · 2018
Pericyte control of blood flow in intraocular islet grafts impacts glucose homeostasis in mice.
10.2337/db21-1104 · 2022
Pericyte dysfunction and impaired vasomotion are hallmarks of islets during the pathogenesis of type 1 diabetes.
10.1016/j.celrep.2023.112913 · 2023
Parallel genome-scale CRISPR-Cas9 screens uncouple human pluripotent stem cell identity versus fitness.
10.1038/s41467-024-53284-4 · 2024
CRISPR screening uncovers a central requirement for HHEX in pancreatic lineage commitment and plasticity restriction.
10.1038/s41556-022-00946-4 · 2022
CRISPR screening uncovers a long-range enhancer for ONECUT1 in pancreatic differentiation and links a diabetes risk variant.
10.1016/j.celrep.2024.114640 · 2024
QSER1 protects DNA methylation valleys from de novo methylation.
10.1126/science.abd0875 · 2021
Dynamic network-guided CRISPRi screen identifies CTCF-loop-constrained nonlinear enhancer gene regulatory activity during cell state transitions.
10.1038/s41588-023-01450-7 · 2023
Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs.
10.1126/science.adl4793 · 2024
Targeting the cytoskeleton to direct pancreatic differentiation of human pluripotent stem cells.
10.1038/s41587-020-0430-6 · 2020
Depolymerizing F-actin accelerates the exit from pluripotency to enhance stem cell-derived islet differentiation.
2025
Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells.
10.1038/s41587-022-01219-z · 2022
Aberrant metabolite trafficking and fuel sensitivity in human pluripotent stem cell-derived islets.
10.1016/j.celrep.2023.112970 · 2023
Stem-cell-derived beta cells mature metabolically upon murine engraftment.
10.1007/s00125-025-06474-8 · 2025
Scalable generation of 3D pancreatic islet organoids from human pluripotent stem cells in suspension bioreactors.
10.1016/j.xpro.2023.102580 · 2023
Circadian entrainment triggers maturation of human in vitro islets.
10.1016/j.stem.2019.11.011 · 2020
Genetic protection from type 1 diabetes resulting from accelerated insulin mRNA decay.
10.1016/j.cell.2025.02.018 · 2025
Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?).
10.1038/s41574-020-00443-4 · 2021
Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes.
10.1007/s00125-022-05812-4 · 2023
The role of β cell stress and neo-epitopes in the immunopathology of type 1 diabetes.
10.3389/fendo.2020.624590 · 2020
Human islet T cells are highly reactive to preproinsulin in type 1 diabetes.
10.1073/pnas.2107208118 · 2021
Modeling human T1D-associated autoimmune processes.
10.1016/j.molmet.2021.101417 · 2022
Baricitinib and β-cell function in patients with new-onset type 1 diabetes.
10.1056/nejmoa2306691 · 2023
Teplizumab: a disease-modifying therapy for type 1 diabetes that preserves β-cell function.
10.2337/dc23-0675 · 2023
Future directions and clinical trial considerations for novel islet β-cell replacement therapies for type 1 diabetes.
10.2337/dbi24-0037 · doi-reference
Stem cell-derived islets: next steps for histologic and functional assessment during development as a cellular therapy for the treatment of diabetes.
10.2337/dbi18-0054 · doi-reference
Regulatory approval of islet transplantation for treatment of type 1 diabetes: Implications and what is on the horizon.
10.1016/j.ymthe.2023.10.011 · doi-reference
Identifying and optimizing critical process parameters for large-scale manufacturing of iPSC derived insulin-producing β-cells.
10.1186/s13287-024-03973-0 · doi-reference
Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes.
10.1016/j.stem.2023.04.002 · doi-reference
Bioreactor-produced iPSCs-derived dopaminergic neuron-containing neural microtissues innervate and normalize rotational bias in a dose-dependent manner in a Parkinson rat model.
10.1016/j.neurot.2024.e00436 · doi-reference
Engineering 3D micro-compartments for highly efficient and scale-independent expansion of human pluripotent stem cells in bioreactors.
10.1016/j.biomaterials.2023.122033 · doi-reference
A nanofibrous encapsulation device for safe delivery of insulin-producing cells to treat type 1 diabetes.
10.1126/scitranslmed.abb4601 · doi-reference
An inverse-breathing encapsulation system for cell delivery.
10.4028/b-doxv17 · doi-reference
A bioinspired scaffold for rapid oxygenation of cell encapsulation systems.
10.1038/s41467-021-26126-w · doi-reference
Designing a retrievable and scalable cell encapsulation device for potential treatment of type 1 diabetes.
10.1073/pnas.1708806115 · doi-reference
Pancreatic islet cryopreservation by vitrification achieves high viability, function, recovery and clinical scalability for transplantation.
10.1038/s41591-022-01718-1 · doi-reference
Enhanced development of functional human NK cells in NOD-scid-IL2rg(null) mice expressing human IL15.
10.1096/fj.202200045r · doi-reference
Humanized mouse models for immuno-oncology research.
10.1038/s41571-022-00721-2 · doi-reference
The anti-CD40L monoclonal antibody AT-1501 promotes islet and kidney allograft survival and function in nonhuman primates.
10.1126/scitranslmed.adf6376 · doi-reference
Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
10.2337/diabetes.48.7.1473 · doi-reference
Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154.
10.1073/pnas.96.14.8132 · doi-reference
The EV antibody database: an interactive database of curated antibodies for extracellular vesicle and nanoparticle research.
10.1016/j.vesic.2024.100040 · doi-reference
Immune engineered extracellular vesicles to modulate T cell activation in the context of type 1 diabetes.
10.1126/sciadv.adg1082 · doi-reference
Localization of drug biodistribution in a 3D-bioengineered subcutaneous neovascularized microenvironment.
10.1016/j.mtbio.2022.100390 · doi-reference
Modeling of a bioengineered immunomodulating microenvironment for cell therapy.
10.1002/adhm.202304003 · doi-reference
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead.
10.1038/s41574-024-01029-0 · doi-reference
Neovascularized implantable cell homing encapsulation platform with tunable local immunosuppressant delivery for allogeneic cell transplantation.
10.1016/j.biomaterials.2020.120232 · doi-reference
The impact of locally-delivered tacrolimus-releasing microspheres and polyethylene glycol-based islet surface modification on xenogeneic islet survival.
10.1016/j.jconrel.2021.06.020 · doi-reference
Immunosuppressive PLGA TGF-β1 microparticles induce polyclonal and antigen-specific regulatory T cells for local immunomodulation of allogeneic islet transplants.
10.3389/fimmu.2021.653088 · doi-reference
Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab.
10.1111/j.1600-6143.2010.03073.x · doi-reference
Long-term outcomes with islet-alone and islet-after-kidney transplantation for type 1 diabetes in the clinical islet transplantation consortium: the CIT-08 study.
10.2337/dc21-2688 · doi-reference
Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes.
10.1111/ajt.16174 · doi-reference
Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia.
10.2337/dc15-1988 · doi-reference
Combinatorial genetic engineering strategy for immune protection of stem cell-derived beta cells by chimeric antigen receptor regulatory T cells.
10.1016/j.celrep.2024.114994 · doi-reference
Selective deletion of human leukocyte antigens protects stem cell-derived islets from immune rejection.
10.1016/j.celrep.2021.109538 · doi-reference
Survival of transplanted allogeneic beta cells with no immunosuppression.
10.1056/nejmoa2503822 · doi-reference
Hypoimmune CD19 CAR T cells evade allorejection in patients with cancer and autoimmune disease.
10.1016/j.stem.2025.07.009 · doi-reference
Human hypoimmune primary pancreatic islets avoid rejection and autoimmunity and alleviate diabetes in allogeneic humanized mice.
10.1126/scitranslmed.adg5794 · doi-reference
Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques.
10.1038/s41587-023-01784-x · doi-reference
Hypoimmune islets achieve insulin independence after allogeneic transplantation in a fully immunocompetent non-human primate.
10.1016/j.stem.2024.02.001 · doi-reference
Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression.
10.1111/ajt.17162 · doi-reference
Teplizumab and β-cell function in newly diagnosed type 1 diabetes.
10.1056/nejmoa2308743 · doi-reference